Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of LUMIFY Preservative Free redness reliever eye drops, the first and only preservative-free over-the-counter eye drops with low-dose brimonidine tartrate 0.025% that relieve redness of the eye due to minor eye irritations.

“Consumers often say how amazed they are at the difference our original LUMIFY makes to their eyes, with over 50,000 five-star reviews as proof,” said John Ferris, president, Consumer, Bausch + Lomb. “LUMIFY Preservative Free brings that same fast-acting formula to those with sensitive eyes — delivering a visibly brighter, whiter look in just 60 seconds.”

Before LUMIFY eye drops were introduced in 2018, redness relievers relied on the same ingredients for decades, which had well known side effects. LUMIFY and LUMIFY Preservative Free are the only over-the-counter redness relievers that selectively target eye redness and offer excellent results with a lower risk of rebound redness and loss of efficacy when used as directed.

“LUMIFY delivers consistently proven results for patients experiencing eye redness,” said Melissa Toyos, MD, and partner, Toyos Clinic, Nashville, TN. “With LUMIFY Preservative Free, my patients with eye sensitivities now have an option that’s just as effective as the original LUMIFY redness reliever eye drops.”

LUMIFY Preservative Free is now available in convenient single-use vials at most U.S. retailers nationwide, including Walmart, Target, CVS, Walgreens, Rite Aid and Amazon. The eye drops will have a manufacturer's suggested retail price of $26.99 and feature updated premium packaging consistent with LUMIFY.

For more information on the LUMIFY brand visit www.lumifyeyes.com.

About the LUMIFY Brand
The LUMIFY brand began in 2018 with the U.S. launch of LUMIFY redness reliever eye drops. They are the No. 1 eye doctor recommended redness reliever eye drop brand with approximately 90% of doctor recommendations¹ and have grown double digits every year since launching. In 2023, Bausch + Lomb introduced LUMIFY EYE ILLUMINATIONS™, a line of specialty eye care products specifically developed for the sensitive area around the eyes. The FDA approved LUMIFY Preservative Free eye drops in April 2024. For more information on the LUMIFY brand, visit www.lumifyeyes.com.

About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

References

1. IQVIA, Average Share of Weekly Doctor Recommendations, January to March 2025.

©2025 Bausch + Lomb.
LUM.0130.USA.25

View source version on businesswire.com: https://www.businesswire.com/news/home/20250521220586/en/

Media Contact:

Kristy Marks

kristy.marks@bausch.com

(908) 927-0683

Source: Bausch + Lomb Corporation